Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublications en collaboration avec des chercheurs de University of Michigan–Ann Arbor (38)
2024
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
Development and external validation of the 'Global Surgical-Site Infection' (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery
British Journal of Surgery, Vol. 111, Núm. 6
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 9, Núm. 1
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116
-
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncology, Vol. 8, Núm. 3
-
Recent Technical Developments in ASL: A Review of the State of the Art
Magnetic Resonance in Medicine, Vol. 88, Núm. 5, pp. 2021-2042
-
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
BLOOD CANCER DISCOVERY, Vol. 3, Núm. 6
2021
-
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547
-
Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features
JAMA Network Open, Vol. 4, Núm. 7
-
Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)
Intensive Care Medicine
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)
EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
-
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169
2020
-
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Leukemia, Vol. 34, Núm. 12, pp. 3298-3309
-
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912